chr9-98293775-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_005458.8(GABBR2):c.2660+10T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000572 in 1,354,464 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00058 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00057 ( 1 hom. )
Consequence
GABBR2
NM_005458.8 intron
NM_005458.8 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.29
Genes affected
GABBR2 (HGNC:4507): (gamma-aminobutyric acid type B receptor subunit 2) The multi-pass membrane protein encoded by this gene belongs to the G-protein coupled receptor 3 family and GABA-B receptor subfamily. The GABA-B receptors inhibit neuronal activity through G protein-coupled second-messenger systems, which regulate the release of neurotransmitters, and the activity of ion channels and adenylyl cyclase. This receptor subunit forms an active heterodimeric complex with GABA-B receptor subunit 1, neither of which is effective on its own. Allelic variants of this gene have been associated with nicotine dependence.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 9-98293775-A-C is Benign according to our data. Variant chr9-98293775-A-C is described in ClinVar as [Benign]. Clinvar id is 462135.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 89 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABBR2 | NM_005458.8 | c.2660+10T>G | intron_variant | ENST00000259455.4 | NP_005449.5 | |||
GABBR2 | XM_017015331.3 | c.2366+10T>G | intron_variant | XP_016870820.1 | ||||
GABBR2 | XM_005252316.6 | c.1886+10T>G | intron_variant | XP_005252373.1 | ||||
GABBR2 | XM_017015332.3 | c.1886+10T>G | intron_variant | XP_016870821.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABBR2 | ENST00000259455.4 | c.2660+10T>G | intron_variant | 1 | NM_005458.8 | ENSP00000259455.2 | ||||
GABBR2 | ENST00000637410.1 | n.2438+10T>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000585 AC: 89AN: 152244Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
89
AN:
152244
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000649 AC: 158AN: 243370Hom.: 0 AF XY: 0.000617 AC XY: 81AN XY: 131376
GnomAD3 exomes
AF:
AC:
158
AN:
243370
Hom.:
AF XY:
AC XY:
81
AN XY:
131376
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000571 AC: 686AN: 1202102Hom.: 1 Cov.: 16 AF XY: 0.000561 AC XY: 342AN XY: 609454
GnomAD4 exome
AF:
AC:
686
AN:
1202102
Hom.:
Cov.:
16
AF XY:
AC XY:
342
AN XY:
609454
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000584 AC: 89AN: 152362Hom.: 0 Cov.: 33 AF XY: 0.000470 AC XY: 35AN XY: 74514
GnomAD4 genome
AF:
AC:
89
AN:
152362
Hom.:
Cov.:
33
AF XY:
AC XY:
35
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Epileptic encephalopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
GABBR2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 18, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at